LFCR logo

LFCR
Lifecore Biomedical Inc

660
Mkt Cap
$201.63M
Volume
164,501.00
52W High
$8.98
52W Low
$3.63
PE Ratio
-4.10
LFCR Fundamentals
Price
$5.35
Prev Close
$5.38
Open
$5.38
50D MA
$5.74
Beta
1.38
Avg. Volume
484,331.44
EPS (Annual)
-$1.27
P/B
-14.12
Rev/Employee
$317,406.40
$403.98
Loading...
Loading...
News
all
press releases
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Receives Average Recommendation of "Hold" from Analysts
Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Lifecore Biomedical (LFCR) to Release Earnings on Thursday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Thursday, April 2. (View Earnings Report at...
MarketBeat·25d ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research
Barrington Research reiterated an "outperform" rating and issued a $5.50 price target on shares of Lifecore Biomedical in a research report on Tuesday...
MarketBeat·27d ago
News Placeholder
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029
Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a standalone CDMO after divesting its former food...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five ratings firms that are covering the company, Marketbeat.com...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Upgraded to Outperform at Barrington Research
Barrington Research upgraded Lifecore Biomedical from a "market perform" rating to an "outperform" rating and set a $5.50 price objective on the stock in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical Q4 Earnings Call Highlights
Lifecore Biomedical (NASDAQ:LFCR) used its fiscal fourth-quarter earnings call to highlight revenue growth, improving margins, and continued cost reductions during its transition to a calendar-year...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Down 2.9% - Here's Why
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Down 2.9% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Shares Up 1.4% - Should You Buy?
Lifecore Biomedical (NASDAQ:LFCR) Trading Up 1.4% - Here's Why...
MarketBeat·2mo ago
News Placeholder
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM...
PR Newswire·3mo ago
<
1
2
...
>

Latest LFCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.